» Articles » PMID: 30458752

First Trimester Medication Use in Pregnancy in Cameroon: a Multi-hospital Survey

Overview
Publisher Biomed Central
Date 2018 Nov 22
PMID 30458752
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a paucity of epidemiological data on medication use in pregnancy in Cameroon.

Methods: Between March and August 2015, 795 pregnant women attending 8 urban and 12 rural hospitals in Cameroon for antenatal (ANC) or other care were interviewed on first trimester medication use using structured questionnaires. Multivariate logistic regression was used to analyse the association of 18 sociodemographic factors with medication use.

Results: A total of 582 (73.2%) women took at least one orthodox (Western) medication during the first trimester, 543 (68.3%) women a non-pregnancy related orthodox medication, and 336 (42.3%)women a pregnancy related orthodox medication. 44% of the women took anti-infectives including antimalarials (33.6%) and antibiotics (20.8%).The other most common medications were analgesics (48.8%) and antianaemias (38.6%). Sulfadoxine/pyrimethamine, contraindicated in the first trimester of pregnancy, was the most commonly used antimalarial(13% of women).0.2% of women reported antiretroviral use. Almost 80% of all orthodox medications consumed by women were purchased from the hospital. 12.8% of the women self-prescribed. Health unit and early gestational age at ANC booking were consistent determinants of prescribing of non-pregnancy related, pregnancy related and anti-infective medications. Illness and opinion on the safety of orthodox medications were determinants of the use of non-pregnancy related medications and anti-infectives. Age and parity were associated only with non-pregnancy related medications.

Conclusion: This study has confirmed the observations of studies across Africa indicating the increasing use of medications during pregnancy. This is an indication that access to medicine is improving and more emphasis now must be placed on medication safety systems targeting pregnant women, especially during the first trimester when the risk of teratogenicity is highest.

Citing Articles

Patterns, Potential Teratogenicity, and Associated Factors of Drugs Prescribed to Pregnant Women Attending Antenatal Care Units in Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia.

Alemu M, Sisay Zewdu W, Ferede Y, Molla Zeleke M, Ayele T, Assefa A Biomed Res Int. 2024; 2024:5577862.

PMID: 39559257 PMC: 11573445. DOI: 10.1155/2024/5577862.


The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications.

Belsti Y, Mousa A, Jackson H, Moran L, Palmer K, Dhungana R Drug Saf. 2024; 48(1):87-97.

PMID: 39302513 PMC: 11711702. DOI: 10.1007/s40264-024-01482-w.


Prevalence of systemic antibacterial use during pregnancy worldwide: A systematic review.

Guimaraes F, Dal-Pizzol T, Silveira M, Bertoldi A PLoS One. 2024; 19(9):e0309710.

PMID: 39240933 PMC: 11379220. DOI: 10.1371/journal.pone.0309710.


Prevalence and associated factors of self-medication in worldwide pregnant women: systematic review and meta-analysis.

Bouqoufi A, Laila L, Boujraf S, Hadj F, Razine R, Abouqal R BMC Public Health. 2024; 24(1):308.

PMID: 38279083 PMC: 10821266. DOI: 10.1186/s12889-023-17195-1.


Self-medication practice among pregnant and postpartum women attending the regional hospital center of Souss Massa, Morocco: a cross-sectional study.

Bouqoufi A, Lahlou L, Hadj F, Boujraf S, Abdessadek M, Khabbal Y Front Pharmacol. 2024; 14:1233678.

PMID: 38259286 PMC: 10800875. DOI: 10.3389/fphar.2023.1233678.


References
1.
Mohammed M, Bushra A, Aljadhey H, Ahmed J . Supplement Use Among Pregnant Women in Ethiopia: Prevalence and Predictors. Ther Innov Regul Sci. 2018; 47(4):416-423. DOI: 10.1177/2168479013485078. View

2.
Say L, Chou D, Gemmill A, Tuncalp O, Moller A, Daniels J . Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2(6):e323-33. DOI: 10.1016/S2214-109X(14)70227-X. View

3.
Achidi E, Kuoh A, Minang J, Ngum B, Achimbom B, Motaze S . Malaria infection in pregnancy and its effects on haemoglobin levels in women from a malaria endemic area of Fako Division, South West Province, Cameroon. J Obstet Gynaecol. 2005; 25(3):235-40. DOI: 10.1080/01443610500060628. View

4.
Yang T, Walker M, Krewski D, Yang Q, Nimrod C, Garner P . Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiol Drug Saf. 2008; 17(3):270-7. DOI: 10.1002/pds.1538. View

5.
Adam M, Polifka J, Friedman J . Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011; 157C(3):175-82. DOI: 10.1002/ajmg.c.30313. View